Telemedicine for allergic patients during COVID‐19

Pattini, Stefano; Malizia, Velia; Travaglini, Alessandro; Brighetti, Maria Antonia; Giustina, Auro Della; Sfika, Ifigenia; Bucchianico, A. Di; Tripodi, Salvatore

doi:10.1111/pai.13346

Cited by 7 publications

(9 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic has SHAPED the ways medical services are conducted in order to accommodate for the imposed lockdown and social distancing measures. Accordingly, telemedicine was adopted by many physicians to guide the treatment and follow-up of allergic patients 152 .…”

Section: Management Of Allergic Diseases During the Covid-19 Pandemicmentioning

confidence: 99%

Recent developments in the immunopathology of COVID-19

Gao

Zhang

Sun

et al. 2022

Preprint

View full text Add to dashboard Cite

There has been an important change in the clinical characteristics and immune profile of COVID-19 patients during the pandemic thanks to the extensive vaccination programs. Here, we highlight recent studies on COVID-19, from the clinical and immunological characteristics to the protective and risk factors for severity and mortality of COVID-19. The efficacy COVID-19 vaccines and potential allergic reactions after administration are also discussed. The occurrence of new variants of concerns such as Omicron BA.2, BA.4 and BA.5 and the global administration of COVID-19 vaccines have changed the clinical scenario of COVID-19. Multisystem inflammatory syndrome in children (MIS-C) has been identified as an important cause of death of children with COVID-19. Perturbations in immunity of T cells, B cells, and mast cells, as well as autoantibodies and metabolic reprogramming may contribute to the long-term symptoms of COVID-19. Atopic diseases, such as allergic asthma and rhinitis, have been shown to be associated with a lower susceptibility and better outcomes of COVID-19. At the beginning of pandemic, EAACI developed guidelines that provided timely information for the management of allergic diseases and preventive measures to reduce transmission in the allergic clinics. The global distribution of COVID-19 vaccines and emerging SARS-CoV-2 variants with reduced pathogenic potential dramatically decreased the morbidity, severity, and mortality of COVID-19. Nevertheless, breakthrough infection remains a challenge for disease control. Hypersensitivity reactions (HSR) to COVID-19 vaccines are low compared to other vaccines, and these were addressed in EAACI statements that provided indications for the management of allergic reactions, including anaphylaxis to COVID-19 vaccines. We have gained a depth knowledge and experience in the over 2 years since the start of the pandemic, and yet a full eradication of SARS-CoV-2 is not on the horizon. Novel strategies are warranted to prevent severe disease in high-risk groups, the development of MIS-C and long COVID.

show abstract

Section: Management Of Allergic Diseases During the Covid-19 Pandemicmentioning

confidence: 99%

Recent developments in the immunopathology of COVID-19

Gao

Zhang

Sun

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…During the COVID-19 pandemic, these shortcomings surfaced even more prominently. 26 Therefore, there is an unmet need to create transparency and objectivity on the benefits and quality criteria of currently available e-health applications in this medical domain. 27 At present, no international consensus on quality standards or criteria for ehealth tools in the areas of asthma, allergic rhinitis, and chronic rhinosinusitis exists, despite availability of a multitude of e-health tools.…”

Section: Introductionmentioning

confidence: 99%

Digital tools in allergy and respiratory care

Verhoeven

Rouadi

Jaoude

et al. 2022

World Allergy Organization Journal

View full text Add to dashboard Cite

“…

The health emergency constituted by the coronavirus disease 2019 (COVID-19) pandemic has determined and still causes many changes in our lives, by spreading smart working, distance learning, virtual conferences, teleconferences, and telemedicine. [1][2][3] In this context, we asked ourselves: what technological tools do we have at our disposal to help allergy sufferers deal with spring and the critical seasons? What kind of information is presented on air quality, in its various components, and on any synergistic effects between allergenic pollens and pollutants of anthropogenic origin?

…”

mentioning

confidence: 99%

Approximate or accurate? Efficacy of daily use of weather and air quality mobile applications for pollen allergy sufferers?

Travaglini

Brighetti

Giustina

et al. 2022

Pediatric Allergy Immunology

Self Cite

View full text Add to dashboard Cite

Nowadays, technology permeates every aspect of human activity, from the professional to the recreational side, and the recent pandemic crisis has only amplified a clearly defined trend. Through portable devices, people play, work, and get information. The immediacy of information and of many aspects of our life is a condition that, once acquired, is difficult to give up. However, immediate information must also be correct, and not all issues can easily be simplified to the point of being understandable in the absence of basic theoretical notions to a large audience. This aspect is particularly relevant when dealing with issues related to human health and the communication problems encountered in recent months concerning the spread of SARS‐CoV‐2, and the vaccination campaign is there to prove it. With the intent of clarifying the advantages and disadvantages of fast and accessible information, in this article, some of the most widespread applications for mobile devices, dedicated to pollen allergens, air quality, parks, gardens, and green areas, were examined. A widespread lack of clarity on the sources of the data and on the criteria used to formulate synthetic judgments—that often confuse the final users—was noted.

show abstract

Telemedicine for allergic patients during COVID‐19

Cited by 7 publications

References 10 publications

Recent developments in the immunopathology of COVID-19

Recent developments in the immunopathology of COVID-19

Digital tools in allergy and respiratory care

Approximate or accurate? Efficacy of daily use of weather and air quality mobile applications for pollen allergy sufferers?

Contact Info

Product

Resources

About